Clinical trial

OMEGA, Local Ablative Therapy in Oligometastatic NSCLC

NCT03827577

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-10-01

PhasePHASE3

Study timeline

Study start (actual)2019-10-01Date precision: day

Registry last updated2020-01-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

Surgical removal of primary and/or of all oligometastasesPROCEDURE

Non-surgical LATRADIATION

Standard medical therapyDRUG

Sponsors & collaborators

Azienda Ospedaliera Universitaria Integrata Veronalead sponsor

A.O.U. Città della Salute e della Scienza - Molinette Hospitalcollaborator

San Luigi Gonzaga Hospitalcollaborator

Regina Elena Cancer Institutecollaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCScollaborator

Azienda Ospedaliera San Camillo Forlaninicollaborator

Fondazione IRCCS Istituto Nazionale dei Tumori, Milanocollaborator

Humanitas Research Hospital IRCCS, Rozzano-Milancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03827577 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.